Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,428 | -10,574 | -5,334 | -14,077 | -10,625 |
| Depreciation Amortization | 6,344 | 4,172 | 2,073 | 8,070 | 5,997 |
| Accounts receivable | 333 | -81 | -528 | 244 | -1,375 |
| Accounts payable and accrued liabilities | 397 | 160 | 211 | -131 | 533 |
| Other Working Capital | 494 | -120 | -1,266 | -1,059 | -1,561 |
| Other Operating Activity | 3,067 | 2,448 | 1,622 | 1,815 | 2,123 |
| Operating Cash Flow | $-5,791 | $-3,996 | $-3,222 | $-5,137 | $-4,907 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -43 | -5 | -376 | -433 |
| Investing Cash Flow | $-48 | $-43 | $-5 | $-376 | $-433 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -3,541 | -3,541 |
| Common Stock Issued | 750 | 750 | 750 | 4,691 | 4,679 |
| Common Stock Repurchased | -92 | -73 | -23 | -135 | -135 |
| Dividend Paid | -25 | -17 | -10 | -55 | -42 |
| Financing Cash Flow | $634 | $660 | $717 | $959 | $961 |
| Exchange Rate Effect | 40 | 52 | -35 | -171 | -18 |
| Beginning Cash Position | 12,497 | 12,497 | 12,497 | 17,222 | 17,222 |
| End Cash Position | 7,332 | 9,170 | 9,952 | 12,497 | 12,825 |
| Net Cash Flow | $-5,166 | $-3,328 | $-2,545 | $-4,724 | $-4,397 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,791 | -3,996 | -3,222 | -5,137 | -4,907 |
| Capital Expenditure | -48 | -43 | -5 | -376 | -433 |
| Free Cash Flow | -5,839 | -4,039 | -3,227 | -5,512 | -5,340 |